News Detail
New Delhi, 31 Aug 2024: A Division Bench of the Delhi High Court has issued an interim order in relief to several companies who approached the Court against the Centre's recent notifications banning fixed dose combinations (FDCs) stating them as irrational combinations.
View Details
Source : DrugsControl Media Services
Division Bench of the Delhi High Court
interim order
notifications
fixed dose combinations
FDCs
irrational combinations
Mankind Pharma
Indoco Remedies
Leeford Healthcare
Obsurge Biotech
Navil Laboratories
Vilco Laboratories
beclomethasone dipropionate
neomycin sulphate
clotrimazole
lignocaine
omeprazole magnesium
dicyclomine
naphazoline
paracetamol
flavoxate
Vilco Laboratories Pvt Ltd & Ors vs UoI & Anr
Delhi High Court
W.P.(C) 11882/2024 & CM Appl. 49475/2024
CM Appl. 49476/2024
CM Appl. 49477/2024
D/o 29.08.2024
Related News
- Gilead Sciences agrees to license new HIV prevention drug to 120 countries (06-10-2024)
- Five sentenced to 10 year rigorous imprisonment for smuggling Ketamine (06-10-2024)
- Treated by fake doctor without MBBS who was working as RMO for five years (06-10-2024)
- 'Create rare diseases fund': Delhi HC to Centre (06-10-2024)
- 10th pass Ramkishore of Bandikui became doctor by putting photo on the documents of Ramkishore of Dungarpur (06-10-2024)
- Fake call centres selling Viagra, duping people in loan fraud busted, 36 arrested (05-10-2024)
- SHEOHAR: Raid on illegal nursing home and medical shop, medicines worth Rs 5 lakh seized (05-10-2024)
- Iron tablets prime target of illegal med producers (05-10-2024)
- DEA Issues Warning About Illegal Online Pharmacies (05-10-2024)
- NCC-PVPI writes not to prescribe/use Nimesulide formulations in Children under 12 years (04-10-2024)